Both Switzerland and the United Kingdom are known for being industry leaders in all aspects related to Cell and Gene Therapy. It is for this reason that the Swiss Business Hub UK is holding an event, in partnership with Switzerland Global Enterprise, in Cambridge on 6 June, to promote the exchange of best practices and key learnings from the respective ecosystems in each country.

The Swiss pharmaceutical company Novartis has recently announced its intention to invest up to 90 million Swiss francs to build a production facility for innovative cell and gene therapies. What does this mean for Switzerland's research landscape? And how can the United Kingdom benefit from this? We are bringing the UK and Swiss sectors together for a joint discussion on current key topics with regards to R&D, business opportunities and future ambitions. Join us for an afternoon filled with exciting  presentations and networking opportunities in one of the world's most prestigious Universities.

Further information can be found here.

‍